文献速递产科

苯肾上腺素输注对剖宫产术后产后失血的影响:一项安慰剂对照随机临床试验

Effect of phenylephrine infusion on postpartum blood loss after cesarean delivery: a placebo-controlled, randomized clinical trial.
PubMed 文献 · Am J Obstet Gynecol MFM · 2025-01-06

这项前瞻性、随机、安慰剂对照、盲法、先导性临床试验纳入106例在脊髓麻醉下剖宫产的低危产妇,比较苯肾上腺素与生理盐水输注对产后24小时失血量的影响。苯肾上腺素组产后失血量中位数显著低于对照组,但作者认为该减少在临床上无重要意义。

要点

  • 苯肾上腺素组产后24小时失血量中位数420 mL,显著低于对照组494 mL(P=0.009)。
  • 苯肾上腺素组失血量>500 mL者占26.4%,显著低于对照组47.1%(P=0.02)。
  • 对照组需要输血者占37.7%,显著高于苯肾上腺素组16.9%(P=0.01)。

核心结论

  • 持续苯肾上腺素输注使脊髓麻醉下剖宫产的低危产妇产后失血量出现统计学显著但临床意义有限的减少。

研究设计与样本

  • 前瞻性、随机、安慰剂对照、盲法、先导性临床试验,共106例接受研究药物并纳入最终分析的低危产妇。

主要发现

  • 苯肾上腺素组产后失血量中位数(四分位距)为420(349-502)mL,对照组为494(397-600)mL,P=0.009。
  • 苯肾上腺素组失血量>500 mL的产妇占26.4%,对照组占47.1%,P=0.02。
  • 对照组需要输血的产妇占37.7%,苯肾上腺素组占16.9%,P=0.01。
  • 苯肾上腺素组分别有6例出现心动过缓和高血压,两组新生儿重症监护室入住、Apgar评分及脐动脉pH可比。

关键数值与推荐

  • 苯肾上腺素每毫升含60微克,输注从脊髓麻醉开始时启动、手术结束时停止,起始速率50微克/分钟,并调整以维持收缩压在基线的80%至120%之间。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preclinical studies have documented the role of alpha-adrenergic agonists in myometrial contraction. Phenylephrine is frequently used to prevent and treat post-spinal hypotension during cesarean delivery. We hypothesized phenylephrine would reduce postpartum blood loss due to alpha-1 receptor-mediated uterine and vascular smooth muscle contraction. OBJECTIVES: This translational study aimed to evaluate the role of phenylephrine in reducing postpartum blood loss due to alpha-1 receptor mediated uterine and vascular smooth muscle contraction. METHODS: This was a prospective, randomized, placebo-controlled, blinded, pilot, clinical trial. Low-risk parturients undergoing cesarean delivery under spinal anesthesia were recruited in this study. The women were randomized to receive phenylephrine or placebo (normal saline) infusion. Each mL of phenylephrine contained 60 micrograms. The study drug began simultaneously with the start of spinal anesthesia, and was stopped at the end of surgery. The infusion rate was started at 50 mcg/min and was titrated to maintain the systolic blood pressure between 80% and 120 % of baseline. The primary outcome measure was postpartum blood loss till 24 hours postpartum, and it was assessed using a surgical swab weighing technique added to suction canister blood contents. The secondary outcomes were incidence of hypertension, hypotension, Apgar score, cord blood gas analysis and neonatal intensive care unit admission (NICU) admission. RESULTS: One hundred six women received study drugs and were eligible for final analysis. The demographic data, obstetric profiles, and medications were comparable. In the phenylephrine group, the mean postpartum blood loss (median [interquartile range]) was significantly lower ([420 {349-502} vs 494 {397-600} mL; p=.009]). Additionally, a significantly lower number of women had >500 mL of blood loss in the phenylephrine group (26.4% vs 47.1%; p=.02). Furthermore, more women in the control arm needed blood transfusion (37.7% vs 16.9%; p=.01). Six women each had bradycardia and hypertension in the phenylephrine group. NICU admission, Apgar score, and umbilical artery PH were comparable. CONCLUSION: Continuous phenylephrine infusion led to a statistically significant but clinically inconsequential reduction in postpartum blood loss in low-risk parturients undergoing cesarean delivery under spinal anesthesia.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Raguramane S, Mishra SK, Jha N, et al. Effect of phenylephrine infusion on postpartum blood loss after cesarean delivery: a placebo-controlled, randomized clinical trial. Am J Obstet Gynecol MFM. 2025. PMID: 39778809. doi:10.1016/j.ajogmf.2024.101593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。